Business | Press Trust of India | Wednesday July 29, 2015
In a strong show, the Rs 550-crore initial public offer (IPO) of biotechnology major Biocon's research arm, Syngene International, was over-subscribed 32.03 times on its last day on Wednesday as both retail and institutional investors bid aggressively for the shares.
www.ndtv.com/business